The COVID-19 pandemic has re-energized the debate on global access to essential medicines.
Access to medicines is a big, complex question. For the Medicines Patent Pool, IP is a critical player in access;...
As the global access debate adapts to the stark inequities exposed by the COVID-19 pandemic, the UN-backed Medicines Patent Pool is emerging as a key player on issues ranging from vaccine tech transfer to making more drugs affordable against the spread of non-communicable diseases like cancer to middle- and low-income countries.
The COVID-19 pandemic has re-energized the debate on global access to essential medicines.
Access to medicines is a big, complex question. For the Medicines Patent Pool, IP is a critical player in access;...
Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.
Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.